IMIGRAN Tablet Ref.[7802] Active ingredients: Sumatriptan

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2021  Publisher: Glaxo Wellcome UK Ltd. trading as GlaxoSmithKline UK., 980 Great West Road, Brentford, Middlesex, TW8 9GS

Product name and form

Imigran 50mg Tablets.

Pharmaceutical Form


50 mg tablet: Pink, film-coated, capsule-shaped, biconvex tablet (of nominal dimensions: 12 mm x 6.5 mm), engraved “50” on one face and plain on the other face.

Qualitative and quantitative composition

50mg sumatriptan base as the succinate salt.

Excipient with known effect:

70 mg lactose monohydrate/tablet.

140 mg lactose/tablet.

For the full list of excipients, see section 6.1.

Active Ingredient Description

Sumatriptan has been demonstrated to be a specific and selective 5-Hydroxytryptamine1 (5HT1D) receptor agonist with no effect on other 5HT receptor (5-HT2 - 5-HT7) subtypes. The vascular 5-HT1D receptor is found predominantly in cranial blood vessels and mediates vasoconstriction.

List of Excipients

Lactose monohydrate
Microcrystalline cellulose
Croscarmellose sodium
Magnesium stearate
Titanium dioxide
Iron oxide

Pack sizes and marketing

Aluminium double foil blister pack or child-resistant foil blister pack in a cardboard carton, containing either 2, 3, 6, 12, 18 or 24 tablets.

Marketing authorization holder

Glaxo Wellcome UK Ltd. trading as GlaxoSmithKline UK., 980 Great West Road, Brentford, Middlesex, TW8 9GS

Marketing authorization dates and numbers

PL 10949/0222



Drug Countries
IMIGRAN Austria, Australia, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.